| Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study AB Docherty, EM Harrison, CA Green, HE Hardwick, R Pius, L Norman, ... BMJ 369, m1985, 2020 | 3792* | 2020 |
| Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury CD Russell, JE Millar, JK Baillie The Lancet 395 (10223), 473-475, 2020 | 2541 | 2020 |
| Genetic mechanisms of critical illness in Covid-19 E Pairo-Castineira, S Clohisey, L Klaric, AD Bretherick, K Rawlik, D Pasko, ... Nature, 2020 | 1472 | 2020 |
| Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score SR Knight, A Ho, R Pius, I Buchan, G Carson, TM Drake, J Dunning, ... BMJ 370, m3339, 2020 | 1178* | 2020 |
| Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia NJ Gadsby, CD Russell, MP McHugh, H Mark, A Conway Morris, ... Clinical Infectious Diseases 62 (7), 817-823, 2016 | 480 | 2016 |
| The Human Immune Response to Respiratory Syncytial Virus Infection CD Russell, SA Unger, M Walton, J Schwarze Clinical Microbiology Reviews 30 (2), 481-502, 2017 | 422 | 2017 |
| Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre … CD Russell, CJ Fairfield, TM Drake, L Turtle, RA Seaton, DG Wootton, ... The Lancet Microbe 2 (8), e354-e365, 2021 | 412* | 2021 |
| Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol L Sigfrid, TM Drake, E Pauley, EC Jesudason, P Olliaro, WS Lim, ... The Lancet Regional Health–Europe 8, 2021 | 363 | 2021 |
| Tissue-specific Immunopathology in Fatal COVID-19 DA Dorward, CD Russell, IH Um, M Elshani, SD Armstrong, ... American Journal of Respiratory and Critical Care Medicine, 2020 | 362 | 2020 |
| Whole genome sequencing reveals host factors underlying critical Covid-19 A Kousathanas, E Pairo-Castineira, K Rawlik, A Stuckey, CA Odhams, ... Nature, 1-10, 2022 | 324 | 2022 |
| SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses MC Swets, CD Russell, EM Harrison, AB Docherty, N Lone, M Girvan, ... The Lancet 399 (10334), 1463-1464, 2022 | 312 | 2022 |
| Comorbidities, multimorbidity and COVID-19 CD Russell, NI Lone, JK Baillie Nature Medicine 29 (2), 334-343, 2023 | 285 | 2023 |
| The utility of peripheral blood leucocyte ratios as biomarkers in infectious diseases: A systematic review and meta-analysis CD Russell, A Parajuli, HJ Gale, NS Bulteel, P Schuetz, CPC de Jager, ... Journal of Infection 78 (5), 339-348, 2019 | 283 | 2019 |
| Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study RK Gupta, EM Harrison, A Ho, AB Docherty, SR Knight, M van Smeden, ... The Lancet Respiratory Medicine 9 (4), 349-359, 2021 | 238 | 2021 |
| Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19 RS Thwaites, A Sanchez Sevilla Uruchurtu, MK Siggins, F Liew, ... Science immunology 6 (57), eabg9873, 2021 | 220 | 2021 |
| Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study TM Drake, AM Riad, CJ Fairfield, C Egan, SR Knight, R Pius, ... The Lancet 398 (10296), 223-237, 2021 | 166 | 2021 |
| Development of two real-time multiplex PCR assays for the detection and quantification of eight key bacterial pathogens in lower respiratory tract infections NJ Gadsby, MP McHugh, CD Russell, H Mark, AC Morris, IF Laurenson, ... Clinical Microbiology and Infection 21 (8), 788, 2015 | 154 | 2015 |
| GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 E Pairo-Castineira, K Rawlik, AD Bretherick, T Qi, Y Wu, I Nassiri, ... Nature 617 (7962), 764-768, 2023 | 135 | 2023 |
| The role of pro‐resolution lipid mediators in infectious disease CD Russell, J Schwarze Immunology 141 (2), 166-173, 2014 | 133 | 2014 |
| Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK AB Docherty, RH Mulholland, NI Lone, CP Cheyne, D De Angelis, ... The Lancet Respiratory Medicine 9 (7), 773-785, 2021 | 125 | 2021 |
Kenneth BaillieProfessor of Experimental Medicine, University of EdinburghVerified email at ed.ac.uk
